|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.21 USD | -1.70% |
|
+2.97% | -5.42% |
| 21/01 | When America Starts to Feel Like a Risky Asset |  |
| 20/01 | Canaccord Genuity Upgrades BioMarin Pharmaceutical to Buy From Hold, Adjusts Price Target to $98 From $84 | MT |
Group BioMarin Pharmaceutical Inc.: Relations chart
Private companies belonging to the same group as BIOMARIN PHARMACEUTICAL INC.
| Company | Manager |
|---|---|
BioMarin International Ltd.
 BioMarin International Ltd. Develops therapeutics | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition